MariMed CFO exercises 53,571 RSUs, tax shares withheld

Mario Pinho, Chief Financial Officer of MariMed Inc., exercised 53,571 Restricted Stock Units into an equal number of common shares on 2025-12-31.

Rhea-AI Filing Summary

Mario Pinho, Chief Financial Officer of MariMed Inc., exercised 53,571 Restricted Stock Units into an equal number of common shares on 2025-12-31. 15,724 shares of common stock were withheld by the company at $0.0891 per share to cover tax obligations, and he now holds 244,814 common shares directly. These RSUs were granted on February 18, 2025 and are fully vested, with no unvested RSUs remaining under this grant.

Insider Trade Summary

53,571 shares exercised/converted

Exercise 3 txns

Insider Pinho Mario

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU)	53,571	$0.00	$0.00
Exercise	Common stock	53,571	$0.00	$0.00
Exercise Price or Tax Liability	Common stock	15,724	$0.0891	$1K

Holdings After Transaction: Restricted Stock Units (RSU) — 0 contracts (Direct); Common stock — 244,814 shares (Direct)

Footnotes (3)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. The RSUs were granted on February 18, 2025; there are no unvested RSUs remaining under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs converted: 53,571 shares Shares withheld for taxes: 15,724 shares Tax withholding price: $0.0891 per share +1 more

4 metrics

RSUs converted 53,571 shares Restricted Stock Units converted into common stock on 2025-12-31

Shares withheld for taxes 15,724 shares Common shares withheld to satisfy tax obligations related to RSU vesting

Tax withholding price $0.0891 per share Per-share reference price on tax-withholding disposition of common stock

Post-transaction holdings 244,814 shares Direct common stock holdings after the reported transactions

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, derivative security, vesting

4 terms

Restricted Stock Units (RSU) financial

"Restricted Stock Units (RSU) convert to shares of common stock on a one-for-one basis"

tax withholding obligations financial

"shares of common stock withheld by the Issuer to satisfy tax withholding obligations"

derivative security financial

"Exercise or conversion of derivative security reported under transaction code M"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vesting financial

"shares withheld in connection with the vesting of RSUs granted on February 18, 2025"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MariMed (MRMD) report for CFO Mario Pinho?

MariMed’s CFO Mario Pinho exercised 53,571 RSUs into common stock on 2025-12-31. In connection with this vesting, 15,724 shares were withheld by the company to satisfy tax obligations, leaving him with 244,814 directly held shares.

How many RSUs did MariMed (MRMD) CFO Mario Pinho convert to common stock?

CFO Mario Pinho converted 53,571 Restricted Stock Units into an equal number of MariMed common shares. The RSUs convert on a one-for-one basis, and this vesting was recorded on 2025-12-31 under a prior RSU grant.

How many MariMed (MRMD) shares were withheld for taxes in this Form 4?

In this Form 4, 15,724 common shares were withheld by MariMed to cover tax withholding obligations tied to the RSU vesting. These shares are reported with a reference price of $0.0891 per share for the tax-related disposition.

What are Mario Pinho’s direct MariMed (MRMD) share holdings after these transactions?

After the reported RSU vesting and tax withholding, CFO Mario Pinho directly holds 244,814 shares of MariMed common stock. This figure reflects his post-transaction ownership as reported in the canonical holdings data for the filing.

Are there any unvested RSUs remaining for MariMed (MRMD) CFO from this grant?

For this specific RSU grant, there are no unvested RSUs remaining. The filing notes that the RSUs, granted on February 18, 2025, are fully vested in accordance with the award agreement between MariMed and CFO Mario Pinho.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/02/2026 - 04:11 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinho Mario

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MA 02062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	12/31/2025		M		53,571	A	$0(1)	260,538	D
Common stock	12/31/2025		F		15,724(2)	D	$0.0891	244,814	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	12/31/2025		M			53,571	(3)	(3)	Common Stock, par value $.001 per share	53,571	$0	0	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The RSUs were granted on February 18, 2025; there are no unvested RSUs remaining under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Mario Pinho	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.